• Home
  • News

Sichenzia Ross Ference Carmel LLP Represents Titan Partners Group in $5.55 Million Public Offering of Seelos Therapeutics

Press Release – New York, NY – December 7th, 2023 – Sichenzia Ross Ference Carmel LLP announced on December 1st that it represented Titan Partners Group, (the “Company”), an institutional investor, in a $5.55 million public offering for Seelos Theraputics Inc.’s common stock (NASDAQ: SEEL). They announced that it has priced its underwritten public offering of 1,781,934 shares of its common stock, pre-funded warrants to purchase up to 2,422,612 shares of its common stock, and accompanying common warrants to purchase up to 4,204,546 shares of its common stock.

Each share of common stock and accompanying common warrant to purchase one share of common stock is being sold at a combined price to the public of $1.32 per share of common stock and accompanying common warrant and each pre-funded warrant and accompanying common warrant to purchase one share of common stock is being sold at a combined price to the public of $1.319 per pre-funded warrant and accompanying common warrant. The pre-funded warrants will be immediately exercisable and will have an exercise price of $0.001 per share. The common warrants will be immediately exercisable, will have an exercise price of $1.32 per share, and will expire on the date that is five years following the closing of the offering. All of the shares of common stock, pre-funded warrants, and accompanying common warrants to be sold in the offering are being sold by Seelos.

Seelos Theraputics, Inc. is a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous system disorders and rare diseases.

Titan Partners Group, a division of American Capital Partners, is acting as sole book-running manager for the offering.

The Sichenzia Ross Ference Carmel LLP team was led by partner Ross Carmel, Of Counsel Shane Wu, and law clerk Soumya Cheedi.

Click here for a full list of recent transactions headed by SRFC.

Sichenzia Ross Ference Carmel LLP